65
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Contrast-Enhanced Ultrasound Parameters and D-Dimer: New Prognostic Parameters for Diffuse Large B-Cell Lymphoma

, , , &
Pages 2535-2544 | Published online: 27 Nov 2023

References

  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
  • Perry AM, Diebold J, Nathwani BN, et al. Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project. Ann Hematol. 2016;95(2):245–251. doi:10.1007/s00277-015-2543-4
  • Lee SJ, Suh CW, Lee SI, et al. Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer’s ring: Nationwide Korean study. Korean J Intern Med. 2014;29(3):352–360. doi:10.3904/kjim.2014.29.3.352
  • Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50(1):74–87. doi:10.1016/j.pathol.2017.09.006
  • Czuczman MS, Grillo-López AJ, Alkuzweny B, et al. Prognostic factors for non-Hodgkin’s lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab. Leuk Lymphoma. 2006;47(9):1830–1840. doi:10.1080/10428190600709523
  • Bo XW, Xu HX, Wang D, et al. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers. Br J Radiol. 2016;89(1067):20160379. doi:10.1259/bjr.20160379
  • Omoto K, Matsunaga H, Take N, et al. Sentinel node detection method using contrast-enhanced ultrasonography with sonazoid in breast cancer: preliminary clinical study. Ultrasound Med Biol. 2009;35(8):1249–1256. doi:10.1016/j.ultrasmedbio.2009.02.004
  • Slaisova R, Benda K, Jarkovsky J, et al. Contrast-enhanced ultrasonography compared to gray-scale and power Doppler in the diagnosis of peripheral lymphadenopathy. Eur J Radiol. 2013;82(4):693–698. doi:10.1016/j.ejrad.2012.12.008
  • Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol. 2002;3(1):27–34. doi:10.1016/S1470-2045(01)00619-2
  • Ay C, Dunkler D, Pirker R, et al. High D-dimer levels are associated with poor prognosis in cancer patients. Haematol-Hematol J. 2012;97(8):1158–1164. doi:10.3324/haematol.2011.054718
  • Li X, Li G, Gao Z, et al. The relative frequencies of lymphoma subtypes in China: a Nationwide study of 10002 cases by the Chinese lymphoma study group. Ann Oncol. 2011;224:141.
  • Jian S, Qunpei Y, Zhaohui L, et al. Distribution of lymphoid neoplasms in China: analysis of 4638 cases according to the world health organization classification. Am J Clin Pathol. 2012;138(3):429–434. doi:10.1309/AJCP7YLTQPUSDQ5C
  • Yang QP, Zhang WY, Yu JB, et al. Subtype distribution of lymphomas in Southwest China: analysis of 6382 cases using WHO classification in a single institution. Diagn Pathol. 2011;6(1):77. doi:10.1186/1746-1596-6-77
  • Rosenberg SA. Validity of the Ann Arbor staging classification for the non-Hodgkin’s lymphomas. Cancer Treat Rep. 1977;61(6):1023–1027.
  • Park AY, Seo BK. Up-to-date Doppler techniques for breast tumor vascularity: superb microvascular imaging and contrast-enhanced ultrasound. Ultrasonography. 2018;37(2):98–106. doi:10.14366/usg.17043
  • Kettenbach J, Helbich TH, Huber S, et al. Computer-assisted quantitative assessment of power Doppler US: effects of microbubble contrast agent in the differentiation of breast tumors. Eur J Radiol. 2005;53(2):238–244. doi:10.1016/j.ejrad.2004.04.017
  • Balleyguier C, Opolon P, Mathieu MC, et al. New potential and applications of contrast-enhanced ultrasound of the breast: own investigations and review of the literature. Eur J Radiol. 2009;69(1):14–23. doi:10.1016/j.ejrad.2008.07.037
  • Wang LA, Wei X, Li Q, et al. The prediction of survival of patients with gastric cancer with PD-L1 expression using contrast-enhanced ultrasonography. Tumour Biol. 2016;37(6):7327–7332. doi:10.1007/s13277-015-4600-y
  • Mitterberger M, Pelzer A, Colleselli D, et al. Contrast-enhanced ultrasound for diagnosis of prostate cancer and kidney lesions. Eur J Radiol. 2007;64(2):231–238. doi:10.1016/j.ejrad.2007.07.027
  • Takada H, Tsuchiya K, Yasui Y, et al. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma. Cancer Med. 2016;5(11):3111–3120. doi:10.1002/cam4.932
  • Liu Z, Guo H, Gao F, et al. Fibrinogen and D-dimer levels elevate in advanced hepatocellular carcinoma: high pretreatment fibrinogen levels predict poor outcomes. Hepatol Res. 2017;47(11):1108–1117. doi:10.1111/hepr.12848
  • Hou C, Jiang F, Ma HT, et al. Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: a multicenter prospective study. Thorac Cancer. 2019;10(2):304–311. doi:10.1111/1759-7714.12956
  • Geng YD, Chen YR, Jin J, et al. Prognostic value of D-Dimer in patients with diffuse large B-cell lymphoma: a retrospective study. Curr Med Sci. 2019;39(2):222–227. doi:10.1007/s11596-019-2023-5